Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
Titel:
Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
Auteur:
Beck, J. Thaddeus Hortobagyi, Gabriel N. Campone, Mario Lebrun, Fabienne Deleu, Ines Rugo, Hope S. Pistilli, Barbara Masuda, Norikazu Hart, Lowell Melichar, Bohuslav Dakhil, Shaker Geberth, Matthias Nunzi, Martina Heng, Daniel Y. C. Brechenmacher, Thomas El-Hashimy, Mona Douma, Shyanne Ringeisen, Francois Piccart, Martine